Synbio Tech

Synbio Tech Financial Leverage

The Financial Leverage (Equity Multiplier) of Synbio Tech (1295.TWO) as of Nov 4, 2026 is 2.32. In the previous year, Financial Leverage (Equity Multiplier) was 2.17 — a change of 6.79% (higher).

Financial Leverage

2.32

YoY

6.79%

Last updated:

Financial Leverage (Equity Multiplier) of Synbio Tech is 2025 2.32 . Financial Leverage (Equity Multiplier) of Synbio Tech was 2024 2.17 . It decreases by 6.79% higher compared to the previous year.

The Synbio Tech Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2020
1.83 TWD
Jan 1, 2021
1.78 TWD
Jan 1, 2022
1.87 TWD
Jan 1, 2023
2.00 TWD
Jan 1, 2024
2.17 TWD
Jan 1, 2025
2.32 TWD
The Synbio Tech Financial Leverage history
YEARFinancial LeverageYoY
2.32+6.79%
2.17+8.58%
2.00+7.09%
1.87+5.17%
1.78-2.76%
1.83—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Synbio Tech Stock analysis

What does Synbio Tech do? Synbio Tech Inc generates revenue through the development and application of lactic acid bacteria, primarily targeting the human health care, livestock and aquaculture, and beverage industries. The company produces lactic acid bacteria powder, starter culture, fermentation broth, and beverages, which are sold as functional human health foods, fermented milk drinks, pet food, and livestock and aquaculture feed additives. Key customers include manufacturers in the health care, food, and agricultural sectors seeking natural probiotic solutions for their products. The firm's product portfolio focuses on lactic acid bacteria-based solutions for diverse applications, including plant preservation and fermented products. By leveraging its R&D capabilities, Synbio Tech Inc supplies raw materials and specialized formulations to businesses aiming to enhance product functionality and shelf life. Its offerings cater to both consumer-facing products and industrial applications in agriculture and food processing. Synbio Tech Inc's business model centers on B2B sales of microbial solutions, with a strong emphasis on health and sustainability trends. The company's main product lines are tailored to meet the growing demand for probiotic-enhanced foods and agricultural inputs, positioning it as a supplier for companies developing functional foods and eco-friendly livestock feed. Synbio Tech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Synbio Tech stock

Financial Leverage (Equity Multiplier) of Synbio Tech is 2.32 in 2025.

Financial Leverage (Equity Multiplier) of Synbio Tech changed from 2.17 to 2.32, representing a 6.79% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Synbio Tech since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Synbio Tech with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Synbio Tech

All Key Metrics — Synbio Tech